Clover Health Investments Yönetim
Yönetim kriter kontrolleri 3/4
Clover Health Investments CEO'su Andrew Toy, Jan2023 tarihinde atandı, in görev süresi 1.83 yıldır. in toplam yıllık tazminatı $ 10.15M olup, şirket hissesi ve opsiyonları dahil olmak üzere 6.9% maaş ve 93.1% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.61% ine doğrudan sahiptir ve bu hisseler $ 10.69M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.3 yıl ve 3.7 yıldır.
Anahtar bilgiler
Andrew Toy
İcra Kurulu Başkanı
US$10.2m
Toplam tazminat
| CEO maaş yüzdesi | 6.9% |
| CEO görev süresi | 1.8yrs |
| CEO sahipliği | 0.6% |
| Yönetim ortalama görev süresi | 2.3yrs |
| Yönetim Kurulu ortalama görev süresi | 3.7yrs |
Son yönetim güncellemeleri
Recent updates
Clover Health: Buy The Dip, Reap The Rewards
Nov 18Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
Nov 08
Clover Health's Rally: The Payoff Of A Profitable Pivot
Nov 06There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump
Oct 03Clover Health: Changing Business Model, Seeking Profitability
Oct 03Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success
Aug 15Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Aug 14Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Aug 06Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jun 12Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues
Apr 20Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07Chamath Palihapitiya-linked Clover Health Investments trading near all-time low
Oct 14Chamath Palihapitiya cuts stake in Clover Health to under 5%
Oct 04Rethinking My Clover Health Position
Sep 12Clover Paid The Price Of Its Alleged Lies; Time To Move On
Aug 17Clover Health Investments to name president Andrew Toy as CEO
Aug 08Clover Health Is A Buy Ahead Of Earnings
Jul 29Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2
Jul 15Is Clover Health A Good Healthcare Sector Stock Pick?
Jun 30CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$96m |
| Jun 30 2024 | n/a | n/a | -US$121m |
| Mar 31 2024 | n/a | n/a | -US$157m |
| Dec 31 2023 | US$10m | US$700k | -US$213m |
| Sep 30 2023 | n/a | n/a | -US$226m |
| Jun 30 2023 | n/a | n/a | -US$268m |
| Mar 31 2023 | n/a | n/a | -US$344m |
| Dec 31 2022 | US$10m | US$500k | -US$340m |
| Sep 30 2022 | n/a | n/a | -US$443m |
| Jun 30 2022 | n/a | n/a | -US$402m |
| Mar 31 2022 | n/a | n/a | -US$615m |
| Dec 31 2021 | US$142m | US$450k | -US$588m |
| Sep 30 2021 | n/a | n/a | -US$527m |
| Jun 30 2021 | n/a | n/a | -US$487m |
| Mar 31 2021 | n/a | n/a | -US$160m |
| Dec 31 2020 | US$9m | US$415k | -US$136m |
| Sep 30 2020 | n/a | n/a | -US$89m |
| Jun 30 2020 | n/a | n/a | -US$145m |
| Mar 31 2020 | n/a | n/a | -US$272m |
| Dec 31 2019 | US$424k | US$400k | -US$364m |
Tazminat ve Piyasa: Andrew 'nin toplam tazminatı ($USD 10.15M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 5.57M ).
Tazminat ve Kazançlar: Andrew 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Andrew Toy (45 yo)
1.8yrs
Görev süresi
US$10,154,701
Tazminat
Mr. Andrew Toy Co-founded Clover Health Investments, Corp. and serves as its Director since November 2018 and served as its President since March 2019. He serves as Chief Executive Officer at Clover Health...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 10.3yrs | Veri yok | 18.01% $ 314.9m | |
| Co-Founder | 1.8yrs | US$10.15m | 0.61% $ 10.7m | |
| General Counsel | 1.1yrs | US$1.47m | 0.28% $ 4.9m | |
| Chief Executive Officer of Home Care | 2.3yrs | US$1.35m | 0.16% $ 2.8m | |
| Chief Executive Officer of Medicare Advantage | 1.8yrs | US$2.49m | 0.26% $ 4.5m | |
| Chief Financial Officer | less than a year | Veri yok | Veri yok | |
| Chief Technology Officer | 2.8yrs | Veri yok | 0.69% $ 12.1m | |
| Head of Investor Relations & Corporate strategy | no data | Veri yok | Veri yok | |
| Chief Compliance Officer | no data | Veri yok | Veri yok | |
| Chief People Officer | no data | Veri yok | Veri yok | |
| Chief Medical Officer of Clover Assistant | 3yrs | Veri yok | Veri yok | |
| Chief Medical Officer | 3.8yrs | Veri yok | Veri yok |
2.3yrs
Ortalama Görev Süresi
46yo
Ortalama Yaş
Deneyimli Yönetim: CLOV 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.3 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 10.3yrs | Veri yok | 18.01% $ 314.9m | |
| Co-Founder | 6yrs | US$10.15m | 0.61% $ 10.7m | |
| Independent Director | 3.8yrs | US$280.93k | 0.066% $ 1.2m | |
| Director | less than a year | Veri yok | Veri yok | |
| Independent Director | 7.8yrs | US$246.55k | 0.067% $ 1.2m | |
| Board Observer | no data | Veri yok | Veri yok | |
| Independent Director | 3.7yrs | US$268.43k | 0.050% $ 877.6k | |
| Independent Director | 2.3yrs | US$250.30k | 0.041% $ 719.1k | |
| Independent Director | 2yrs | US$247.80k | 0.077% $ 1.3m | |
| Lead Independent Director | 3.6yrs | US$320.16k | 0.044% $ 776.8k |
3.7yrs
Ortalama Görev Süresi
50.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: CLOV 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.7 yıldır).